So far IMU’s B-cell results have been like warm and haven’t led to fast tracking like IMM’s and they are years behind IMM with no registrational trials imminent. I guess they have a more diverse platform with the Oncalytic virus stuff but often diversification is required because you are not getting the results in your prime area.
IMM, on the other hand, can stick with Efti because the results speak for themselves and we have a FDA fast track with a Keytruda trial.
Why our share price is so much lower has got me stumped. It certainly doesn’t have anything to do with trial results otherwise the relative share price’s would be reversed. Which is why I disagree with Ahjay. I think Leslie Chong’s industry charisma and ability to attract excitement and investors is the key difference between the two companies.
Let’s hope the spot light on Lag3 finally kicks things off.
- Forums
- ASX - By Stock
- IMM
- Overnight Market report
Overnight Market report, page-310
-
- There are more pages in this discussion • 2,476 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $421.2M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 28.5¢ | $751.3K | 2.589M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 307462 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 118494 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 257462 | 0.285 |
18 | 712543 | 0.280 |
6 | 125918 | 0.275 |
11 | 273188 | 0.270 |
7 | 124774 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 118494 | 4 |
0.300 | 623600 | 3 |
0.305 | 191186 | 8 |
0.310 | 507281 | 6 |
0.315 | 138917 | 6 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online